您的购物车当前为空
别名 GSK3117391A
HDAC-IN-3 (GSK3117391A)是组蛋白脱乙酰酶抑制剂,可治疗慢性炎症性疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
HDAC-IN-3 (GSK3117391A)是组蛋白脱乙酰酶抑制剂,可治疗慢性炎症性疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 612 | In stock | |
| 5 mg | ¥ 1,650 | In stock | |
| 10 mg | ¥ 2,650 | In stock | |
| 25 mg | ¥ 4,390 | In stock | |
| 50 mg | ¥ 6,130 | In stock | |
| 100 mg | ¥ 8,290 | In stock | |
| 200 mg | ¥ 10,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,470 | In stock |
HDAC-IN-3 相关产品
| 产品描述 | HDAC-IN-3 (GSK3117391A) is a potent histone deacetylase (HDAC) inhibitor, and treatment chronic inflammatory disorders. |
| 别名 | GSK3117391A |
| 分子量 | 403.52 |
| 分子式 | C22H33N3O4 |
| CAS No. | 1018673-42-1 |
| Smiles | ONC(=O)CCc1ccc(CN[C@@H](C2CCCCC2)C(=O)OC2CCCC2)cn1 |
| 密度 | no data available |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| 溶解度信息 | DMSO: 4.04 mg/mL (10.01 mM), Sonication is recommended. | ||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 1 mg/mL (2.48 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||
DMSO
| |||||||||||||||||||||
评论内容